Pharmacists Reimagine Myeloma Care With Insights from ASCO
Pharmacy Times
JUNE 24, 2025
This is progressing through a phase 3 trial and includes comparator arms with standard-of-care treatments like daratumumab, bortezomib (Velcade; Millennium/Takeda and Janssen Pharmaceutical Companies), and lenalidomide. 2 We’re still trying to figure out where these new treatments best fit.
Let's personalize your content